AAAAAA

   
Results: 1-22 |
Results: 22
METAANALYSIS OF CHEMOTHERAPY VERSUS COMBINED-MODALITY TREATMENT TRIALS IN HODGKINS-DISEASE
Authors: LOEFFLER M BROSTEANU O HASENCLEVER D SEXTRO M ASSOULINE D BARTOLUCCI AA CASSILETH PA CROWTHER D DIEHL V FISHER RI HOPPE RT JACOBS P PATER JL PAVLOVSKY S THOMPSON E WIERNIK P
Citation: M. Loeffler et al., METAANALYSIS OF CHEMOTHERAPY VERSUS COMBINED-MODALITY TREATMENT TRIALS IN HODGKINS-DISEASE, Journal of clinical oncology, 16(3), 1998, pp. 818-829
POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS
Authors: ABE O ABE R ENOMOTO K KIKUCHI K KOYAMA H NOMURA Y SAKAI K SUGIMACHI K TOMINAGA T UCHINO J YOSHIDA M BENRAADT J VANDEVELDE AO VANDONGEN JA VERMORKEN JB GIOKAS G LISSAIOS B HARVEY VJ HOLDAWAY TM KAY RG MASON BH COATES A FORBES JF FOCAN C LOBELLE JP GATES GD POWELL J DURAND M MAURIAC L BARTHOLOMEUS S PICCART MJ GELMAN RS HENDERSON IC SHAPIRO CL HANCOCK AK MASOOD MB PARKER D PRICE JJ JACKSON S RAGAZ J DELOZIER T MACELESECH J HAYBITTLE JL BERRY D BROADWATER G CIRRINCIONE C MUSS H NORTON L BAUM M HOUGHTON J RILEY D DENT DM GUDGEON CA HACKING A GORDON NH DAVIS HL ROMESTAING P LEHINGUE Y OWEN JR MEIER P HOWELL A RIBEIRO GC SWINDELL R ALBANO J DEOLIVEIRA CF GERVASIO H GORDILHO J CARSTENSEN B PALSHOF T JOHANSEN H KORZENIOWSKI S SKOLYSZEWSKI J PORTNOJ SM ANDERSEN KW AXELSSON CK BLICHERTTOFT M MOURIDSEN HT OVERGAARD M ROSE C CORCORAN N TRAMPISCH HJ COMIS RL DAVIDSON NE GRAY R ROBERT N TORMEY DC WOOD W CHETTY U FORREST P JACK W ROSSBACH J SYLVESTER RJ VANDEVELDE CJH CUNNINGHAM MP BONNETERRE J FUMOLEAU P NAMER M BASTERT G RAUSCHECKER H SAUER R SAUERBREI W SCHAUER A SCHUMACHER M DESCHRYVER A BELFIGLIO M MARI E NICOLUCCI A SCORPIGLIONE N YOSEF HMA MCARDLE CS SMITH DC LARA PC BOCCARDO F RUBAGOTTI A ERAZO A MEDINA JY IZUO M MORISHITA Y BENTLEY A DORAN Z FENTIMAN IS HAYWARD JL RUBENS RD KAUFMANN M JONAT W SCHEURLEN H VONFOURNIER D FOUNTZILAS G KLAFSTROM P BLOMQVIST C CUZICK J MARGREITER R CASTIGLIONE M CAVILLI F COLLINS J FORBES J GELBER RD GOLDHIRSCH A LINDTNER J PRICE KN RUDENSTAM CM SENN HJ BLISS JM CHILVERS CED COOMBES RC MARTY M BOROVIK R BRUFMAN G HAYAT H ROBINSON E WIGLER N PANNUTI F TAKASHIMA S YASUTOMI T SONOO H YAMASHITA J OGAWA M WELVAART K HUPPERETS PSGJ BONTE J TENGRUP I TENNVALLNITTBY L MARTIN P ROMAIN S INGLE JN SUMAN VJ BUZDAR AU SMITH T HAKES T WITTES R DELAHUERTA R SAINZ MG BONADONNA G DELVECCHIO M VALAGUSSA P VERONESI U DUBOIS JB BIANCO AR LIPPMAN ME PIERCE LJ SIMON R STEINBERG SM MYLES JD PATER JL PRITCHARD KI ANDERSON S BROWN A BRYANT J COSTANTINO J DIGNAM J FISHER B REDMOND C WIEAND S WOLMARK N JACKSON IM PALMER MK BENGTSSON NO LARSSON LG LYTHGOE JP KISSIN M HANNISDAL E VARHAUG JE NISSENMEYER R BLAMEY RW MITCHELL AK ROBERTSON JFR UEO H MATHE G MISSET JL ABUZAHRA HT CLARKE EA MCLAUGHLIN JR CLARK RM LEVINE M MORIMOTO K SAWA K TAKATSUKA Y GUNDERSEN S HAUERJENSEN M HOST H CROSSLEY E HARRIS A BEIGHTON A CLARKE M COLLINS R DAVIES C EVANS V GODWIN J GREAVES E HARWOOD C JACKSON D JAMES S LAU E MEAD G NAUGHTEN A PETO R TOOTH A RAMBERT P ASSELAIN B SALMON RJ VILCOQ JR ARRIAGADA R HILL C LAPLANCHE A LE MG SPIELMANN M COCCONI G DIBLASIO B CATALANO R CREECH RH BROCKSCHMIDT J COOPER MR ANDRYSEK O BARKMANOVA J FALKSON CI ABRAHAM M KLIJN JGM TREURNIETDONKER AD VANPUTTEN WLJ EASTON D POWLES TJ GAZET JC SEMIGLAZOV V DESHPANDE N DIMARTINO L DOUGLAS P LINDTNER A NOTTER G BRYANT AJS EWING GH KRUSHENKOSLOSKI JL GEORGE WD GOULD A STEWART HJ STRONER P MOLLER TR RYDEN S CARSTENSEN J HATSCHEK T SODERBERG M CARPENTER JT ALBAIN K CROWLEY J GREEN S MARTINO S OSBORNE CK RAVDIN PM RUTQVIST LE WALLGREN A HOLM LE THURLIMANN B BRENNER H HERCBERGS A YOSHIMOTO M DEBOER G PATERSON AHG MEAKIN JW PANZARELLA T NAJA A BAHI J REID M SPITTLE M SENANAYAKE F BERGH J HOLMBERG L SEVELDA P ZIELINSKY CC GNANT M JAKESZ R BUCHANAN RB CROSS M DUNN JA GILLESPIE WM KELLY K MORRISON JM LITTON A CHLEBOWSKI RT BEZWODA WR CAFFIER H
Citation: O. Abe et al., POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS, Lancet, 352(9132), 1998, pp. 930-942
CAN DIFFERENT TYPES OF RETINAL EMBOLI BE RELIABLY DIFFERENTIATED FROMONE ANOTHER - AN INTEROBSERVER AND INTRAOBSERVER AGREEMENT STUDY
Authors: SHARMA S PATER JL LAM M CRUESS AF
Citation: S. Sharma et al., CAN DIFFERENT TYPES OF RETINAL EMBOLI BE RELIABLY DIFFERENTIATED FROMONE ANOTHER - AN INTEROBSERVER AND INTRAOBSERVER AGREEMENT STUDY, Canadian journal of ophthalmology, 33(3), 1998, pp. 144-148
EXTENT AND VARIATION OF OMEPRAZOLE PRESCRIBING IN AN ELDERLY POPULATION OF ONTARIO
Authors: MCBRIDE JE PATER JL DORLAND JL LAM YM
Citation: Je. Mcbride et al., EXTENT AND VARIATION OF OMEPRAZOLE PRESCRIBING IN AN ELDERLY POPULATION OF ONTARIO, The Annals of pharmacotherapy, 31(4), 1997, pp. 411-416
QUALITY-OF-LIFE SCORES - AN INDEPENDENT PROGNOSTIC VARIABLE IN A GENERAL-POPULATION OF CANCER-PATIENTS RECEIVING CHEMOTHERAPY
Authors: DANCEY J ZEE B OSOBA D WHITEHEAD M LU F KAIZER L LATREILLE J PATER JL
Citation: J. Dancey et al., QUALITY-OF-LIFE SCORES - AN INDEPENDENT PROGNOSTIC VARIABLE IN A GENERAL-POPULATION OF CANCER-PATIENTS RECEIVING CHEMOTHERAPY, Quality of life research, 6(2), 1997, pp. 151-158
FATIGUE IN PATIENTS WITH CANCER - RESULTS WITH NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP STUDIES EMPLOYING THE EORTC QLQ-C30
Authors: PATER JL ZEE B PALMER M JOHNSTON D OSOBA D
Citation: Jl. Pater et al., FATIGUE IN PATIENTS WITH CANCER - RESULTS WITH NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP STUDIES EMPLOYING THE EORTC QLQ-C30, Supportive care in cancer, 5(5), 1997, pp. 410-413
THE ROLE OF THE 5-HT3 ANTAGONISTS ONDANSETRON AND DOLASETRON IN THE CONTROL OF DELAYED-ONSET NAUSEA AND VOMITING IN PATIENTS RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY
Authors: PATER JL LOFTERS WS ZEE B DEMPSEY E WALDE D MOQUIN JP WILSON K HOSKINS P GUEVIN RM VERMA S NAVARI R KROOK JE HAINSWORTH J PALMER M CHIN C
Citation: Jl. Pater et al., THE ROLE OF THE 5-HT3 ANTAGONISTS ONDANSETRON AND DOLASETRON IN THE CONTROL OF DELAYED-ONSET NAUSEA AND VOMITING IN PATIENTS RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY, Annals of oncology, 8(2), 1997, pp. 181-185
PHASE-III DOUBLE-BLIND COMPARISON OF DOLASETRON MESYLATE AND ONDANSETRON AND AN EVALUATION OF THE ADDITIVE ROLE OF DEXAMETHASONE IN THE PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING DUE TO MODERATELY EMETOGENIC CHEMOTHERAPY
Authors: LOFTERS WS PATER JL ZEE B DEMPSEY E WALDE D MOQUIN JP WILSON K HOSKINS P GUEVIN RM VERMAN S NAVARI R KROOK JE HAINSWORTH J PALMER M CHIN C
Citation: Ws. Lofters et al., PHASE-III DOUBLE-BLIND COMPARISON OF DOLASETRON MESYLATE AND ONDANSETRON AND AN EVALUATION OF THE ADDITIVE ROLE OF DEXAMETHASONE IN THE PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING DUE TO MODERATELY EMETOGENIC CHEMOTHERAPY, Journal of clinical oncology, 15(8), 1997, pp. 2966-2973
CAN DIFFERENT TYPES OF RETINAL EMBOLI BE RELIABLY DIFFERENTIATED FROMONE ANOTHER
Authors: CRUESS AF SHARMA S PATER JL LAM M
Citation: Af. Cruess et al., CAN DIFFERENT TYPES OF RETINAL EMBOLI BE RELIABLY DIFFERENTIATED FROMONE ANOTHER, Investigative ophthalmology & visual science, 38(4), 1997, pp. 484-484
OVARIAN ABLATION IN EARLY BREAST-CANCER - OVERVIEW OF THE RANDOMIZED TRIALS
Authors: CLARKE M COLLINS R DAVIES C GODWIN J GRAY R PETO R ABE O ABE R ENOMOTO K KIKUCHI K KOYAMA H NOMURA Y SAKAI K SUGIMACHI K TOMINAGA T UCHINO J YOSHIDA M VANDEVELDE AO VANDONGEN JA VERMORKEN JB ARVELAKIS A GIOKAS G LISSAIOS B HARVEY VJ HOLDAWAY TM KAY RG MASON BH COATES A FORBES JF FOCAN C LOBELLE JP PEEK U OATES GD POWELL J BASTERT G RAUSCHECKER H SAUER R SAUERBREI W SCHAUER A SCHUMACHER M DURAND M MAURIAC L BARTHOLOMEUS S PICCART MJ GELMAN RS HENDERSON IC SHAPIRO CL HANCOCK AK MASOOD MB PARKER D PRICE JJ JACKSON S RAGAZ J DELOZIER T MACELESECH J HAYBITTLE JL CIRRINCIONE C KORZUN A WEISS RB WOOD WC BAUM M HOUGHTON J RILEY D DENT DM GUDGEON CA HACKING A HORGAN K HUGHES L STEWART HJ GORDON NH DAVIS HL LEHINGUE Y OWEN JR MEIER P HOWELL A RIBEIRO GC SWINDELL R ALBANO J DEOLIVEIRA CF GERVASIO H GORDILHO J CARSTENSEN B PALSHOF T JOHANSEN H KORZENIOWSKI S SKOLYSZEWSKI J ANDERSEN KW AXELSSON CK BLICHERTTOFT M MOURIDSEN HT OVERGAARD M ROSE C CORCORAN N TRAMPISCH HJ ABELOFF MD CARBONE PC GLICK J TORMEY DC ROSSBACH J SCANLON EF SCHURMAN S DESCHRYVER A YOSEF HMA MCARDLE CS SMITH DC LARA PC BOCCARDO F ERAZO A MEDINA JY IZUO M MORISHITA Y BENTLEY A DORAN Z FENTIMAN IS HAYWARD JL RUBENS RD KAUFMANN M JONAT W SCHEURLEN H VONFOURNIER D FOUNTZILAS G KLEFSTROM P BLOMQVIST C CUZICK J MARGREITER R CASTIGLIONE M CAVALLI F COLLINS J FORBES J GELBER RD GOLDHIRSCH A LINDTNER J PRICE KN RUDENSTAM CM SENN HJ BLISS JM CHILVERS CED COOMBES RC MARTY M BOROVIK R BRUFMAN G HAYAT H ROBINSON E WIGLER N PANNUTI F TAKASHIMA S TASUTOMI T SONOO H YAMASHITA J OGAWA M HUPPERETS PSGJ BONTE J TENGRUP I TENNVALLNITTBY L MARTIN P ROMAIN S AHMANN D SCHAID DJ BUZDAR AU SMITH T HAKES T NORTON L WITTES R DELAHUERTA R SAINZ MG BONADONNA G DELVECCHIO M VALAGUSSA P VERONESI U DUBOIS JB BIANCO AR LIPPMAN ME PIERCE LJ SIMON R STEINBERG SM BROWN A FISHER B REDMOND C WOLMARK N JACKSON IM PALMER MK INGLE JN SUMAN VJ BENGTSSON NO LARSSON LG LYTHGOE JP KISSIN M HANNISDAL E VARHAUG JE NISSENMEYER R BLAMEY RW MITCHELL AK ROBERTSON JFR NAKAMURA Y MATHE G MISSET JL ABUZAHRA HT CLARKE EA MCLAUGHLIN JR CLARK RM LEVINE M MYLES JD PATER JL PRITCHARD KI MORIMOTO K SAWA K TAKATSUKA Y GUNDERSEN S HAUERJENSEN M HOST A CROSSLEY E DURRANT K HARRIS A BEIGHTON A COLLINS R EVANS V GREAVES E HARWOOD C JAMES S LAU E MEAD G MULDAL A NAUGHTON A TOOTH A WHEATLEY K RAMBERT P ASSELAIN B SALMON RJ VILCOQ JR ARRIAGADA R HILL C LAPLANCHE A LE MG SPEILMANN M COCCONI G DIBLASIO B CATALANO R CREECH RH BROCKSCHMIDT J COOPER MR ANDRYSEK O BARKMANOVA J FALKSON CJ ABRAHAM M KLIJN JGM TREURNIETDONKER AD VANPUTTEN WLJ EASTON D POWLES TJ GAZET JC SEMIGLAZOV V DESHPANDE N DIMARTINO L DOUGLAS P HOST H BRYANT AJS EWING GH KRUSHENKOSLOSKI JL FORREST APM JACK W MCDONALD C MOLLER TR RYDEN S CARSTENSEN J HATSCHEK T SODERBERG M CARPENTER JT ALBAIN K CROWLEY J GREEN S MARTINO S OSBORNE CK RAVDIN PM RUTQVIST LE WALLGREN A HOLM LE YOSHIMOTO M DEBOER G PATERSON AHG MEAKIN JW PANZARELLA T NAJA A BAHI J REID M SPITTLE M SENANAYAKE F BERGH J HOLMBERG L SEVELDA P ZIELINSKY CC JAKESZ R GNANT M BUCHANAN RB CROSS M DUNN JA GILLESPIE WM KELLY K MORRISON JM LITTON A CHLEBOWSKI RT BEZWODA WR CAFFIER H
Citation: M. Clarke et al., OVARIAN ABLATION IN EARLY BREAST-CANCER - OVERVIEW OF THE RANDOMIZED TRIALS, Lancet, 348(9036), 1996, pp. 1189-1196
A PROPOSAL FOR A NEW APPROACH TO INTERGROUP CANCER TRIALS
Authors: PATER JL ZEE B MYLES J PIGNON JP MILAN C SAHMOUD T TORRI V MARSONI S
Citation: Jl. Pater et al., A PROPOSAL FOR A NEW APPROACH TO INTERGROUP CANCER TRIALS, European journal of cancer, 31A(12), 1995, pp. 1921-1923
ANTIEMETIC PROPERTIES OF GRANISETRON
Authors: PATER JL WARR D
Citation: Jl. Pater et D. Warr, ANTIEMETIC PROPERTIES OF GRANISETRON, The New England journal of medicine, 332(24), 1995, pp. 1653-1653
BAYESIAN APPROACHES TO RANDOMIZED TRIALS - DISCUSSION
Authors: GRIEVE AP POCOCK SJ ABRAMS K ASHBY D HEALY MJR JENNISON C LEWIS JA LINDLEY DV MACHIN D NEWMAN GB BATHER JA BAILEY RA EVANS SJW KEIDING N MATTHEWS JNS GORE SM SENN S HERSON J TURNBULL BW ALTMAN DG ARMITAGE P ATKINSON AC BERRY DA BUYSE ME CARLIN BP DEMETS DL DEMPSTER AP DUNSTAN FDJ ELLENBERG SS FAYERS P GAIL MH GEORGE SL GREENHOUSE JB WASSERMAN LA HARRELL FE JOSEPH L SHAPIRO SH KADANE JB LEHMANN HP MARUBINI E MARIANI L PATER JL PETTIT LI YOUNG KDS ROSNER GL WHITEHEAD J WIEAND HS
Citation: Ap. Grieve et al., BAYESIAN APPROACHES TO RANDOMIZED TRIALS - DISCUSSION, Journal of the Royal Statistical Society. Series A. Statistics in society, 157, 1994, pp. 387-416
RESEARCH ON HEALTH-RELATED QUALITY-OF-LIFE - DISSEMINATION INTO PRACTICAL APPLICATIONS
Authors: TILL JE OSOBA D PATER JL YOUNG JR
Citation: Je. Till et al., RESEARCH ON HEALTH-RELATED QUALITY-OF-LIFE - DISSEMINATION INTO PRACTICAL APPLICATIONS, Quality of life research, 3(4), 1994, pp. 279-283
PATTERNS OF FAILURE FOLLOWING LOCO-REGIONAL RADIOTHERAPY IN THE TREATMENT OF LIMITED STAGE SMALL-CELL LUNG-CANCER
Authors: COY P HODSON DI MURRAY N PATER JL PAYNE DG ARNOLD A KOSTASHUK E DIXON P EVANS WK ZEE B SADURA A AYOUB J LEVITT M WIERZBICKI R FELD R MAROUN J WILSON K
Citation: P. Coy et al., PATTERNS OF FAILURE FOLLOWING LOCO-REGIONAL RADIOTHERAPY IN THE TREATMENT OF LIMITED STAGE SMALL-CELL LUNG-CANCER, International journal of radiation oncology, biology, physics, 28(2), 1994, pp. 355-362
TIMING THE COLLABORATIVE ANALYSIS OF 3 TRIALS COMPARING 5-FU PLUS FOLINIC ACID (FUFA) TO SURGERY ALONE IN THE MANAGEMENT OF RESECTED COLORECTAL-CANCER - A NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP (NCIC-CTG) PERSPECTIVE
Authors: PATER JL
Citation: Jl. Pater, TIMING THE COLLABORATIVE ANALYSIS OF 3 TRIALS COMPARING 5-FU PLUS FOLINIC ACID (FUFA) TO SURGERY ALONE IN THE MANAGEMENT OF RESECTED COLORECTAL-CANCER - A NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP (NCIC-CTG) PERSPECTIVE, Statistics in medicine, 13(13-14), 1994, pp. 1337-1340
MODELING TOXICITY AND RESPONSE IN CARBOPLATIN-BASED COMBINATION CHEMOTHERAPY
Authors: EGORIN MJ REYNO LM CANETTA RM JODRELL DI SWENERTON KD PATER JL BURROUGHS JN NOVAK MJ SRIDHARA R
Citation: Mj. Egorin et al., MODELING TOXICITY AND RESPONSE IN CARBOPLATIN-BASED COMBINATION CHEMOTHERAPY, Seminars in oncology, 21(5), 1994, pp. 7-19
ASSESSING THE RELIABILITY OF 2 TOXICITY SCALES - IMPLICATIONS FOR INTERPRETING TOXICITY DATA
Authors: BRUNDAGE MD PATER JL ZEE B
Citation: Md. Brundage et al., ASSESSING THE RELIABILITY OF 2 TOXICITY SCALES - IMPLICATIONS FOR INTERPRETING TOXICITY DATA, Journal of the National Cancer Institute, 85(14), 1993, pp. 1138-1148
A VALIDATION-STUDY OF THE DOMAINS OF THE CORE EORTC QUALITY-OF-LIFE QUESTIONNAIRE
Authors: NIEZGODA HE PATER JL
Citation: He. Niezgoda et Jl. Pater, A VALIDATION-STUDY OF THE DOMAINS OF THE CORE EORTC QUALITY-OF-LIFE QUESTIONNAIRE, Quality of life research, 2(5), 1993, pp. 319-325
IMPACT OF CYCLOPHOSPHAMIDE ON RELATIONSHIPS BETWEEN CARBOPLATIN EXPOSURE AND RESPONSE OR TOXICITY WHEN USED IN THE TREATMENT OF ADVANCED OVARIAN-CANCER
Authors: REYNO LM EGORIN MJ CANETTA RM JODRELL DI SWENERTON KD PATER JL BURROUGHS JN NOVAK MJ SRIDHARA R
Citation: Lm. Reyno et al., IMPACT OF CYCLOPHOSPHAMIDE ON RELATIONSHIPS BETWEEN CARBOPLATIN EXPOSURE AND RESPONSE OR TOXICITY WHEN USED IN THE TREATMENT OF ADVANCED OVARIAN-CANCER, Journal of clinical oncology, 11(6), 1993, pp. 1156-1164
POLYCHEMOTHERAPY IN ADVANCED NON-SMALL-CELL LUNG-CANCER
Authors: PATER JL
Citation: Jl. Pater, POLYCHEMOTHERAPY IN ADVANCED NON-SMALL-CELL LUNG-CANCER, Lancet, 342(8873), 1993, pp. 741-741
POLYCHEMOTHERAPY IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A METAANALYSIS
Authors: SOUQUET PJ CHAUVIN F BOISSEL JP CELLERINO R CORMIER Y GANZ PA KAASA S PATER JL QUOIX E RAPP E TUMARELLO D WILLIAMS J WOODS BL BERNARD JP
Citation: Pj. Souquet et al., POLYCHEMOTHERAPY IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A METAANALYSIS, Lancet, 342(8862), 1993, pp. 19-21
Risultati: 1-22 |